UA88272C2 - Use of polypeptides of the cupredoxin family in cancer therapy - Google Patents

Use of polypeptides of the cupredoxin family in cancer therapy

Info

Publication number
UA88272C2
UA88272C2 UAA200602804A UAA200602804A UA88272C2 UA 88272 C2 UA88272 C2 UA 88272C2 UA A200602804 A UAA200602804 A UA A200602804A UA A200602804 A UAA200602804 A UA A200602804A UA 88272 C2 UA88272 C2 UA 88272C2
Authority
UA
Ukraine
Prior art keywords
polypeptides
cancer therapy
cupredoxin family
methods
cell death
Prior art date
Application number
UAA200602804A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ананда М. Чакрабарти
Тапас К. Дасгупта
Васу Пундж
Ольга Заборина
Тохру Ямада
Йошинори Хираока
Original Assignee
Борд Оф Трастиз Оф Зе Юниверсити Оф Иллинойс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Борд Оф Трастиз Оф Зе Юниверсити Оф Иллинойс filed Critical Борд Оф Трастиз Оф Зе Юниверсити Оф Иллинойс
Publication of UA88272C2 publication Critical patent/UA88272C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Cytotoxic factors having use in modulating cell death, and their use in methods of treating necrosis or apoptosis-related conditions are disclosed. The invention also relates to methods for identifying active agents useful in treating conditions related to cell death or uncontrolled growth.
UAA200602804A 2003-08-15 2004-08-10 Use of polypeptides of the cupredoxin family in cancer therapy UA88272C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41455003P 2003-08-15 2003-08-15

Publications (1)

Publication Number Publication Date
UA88272C2 true UA88272C2 (en) 2009-10-12

Family

ID=37390765

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200602804A UA88272C2 (en) 2003-08-15 2004-08-10 Use of polypeptides of the cupredoxin family in cancer therapy

Country Status (3)

Country Link
CN (1) CN1863545A (en)
UA (1) UA88272C2 (en)
ZA (1) ZA200602126B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
AU2018328223A1 (en) * 2017-09-05 2020-03-12 GLAdiator Biosciences, Inc. Delivery of payloads to stem cells
CN113912675B (en) * 2021-09-23 2023-04-11 中国药科大学 Centipede polypeptide with analgesic activity and application thereof

Also Published As

Publication number Publication date
CN1863545A (en) 2006-11-15
ZA200602126B (en) 2007-09-26

Similar Documents

Publication Publication Date Title
TNSN06059A1 (en) Use of polypeptides of the cupredoxin family in cancer therapy
WO2003103581A3 (en) Compositions and methods for liver growth and liver protection
WO2004030627A3 (en) Synergistic methods and compositions for treating cancer
WO2009064590A3 (en) Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
EP1551812A4 (en) Mitotic kinesin inhibitors
EP1463733A4 (en) Mitotic kinesin inhibitors
EP1481077A4 (en) Mitotic kinesin inhibitors
MY130363A (en) "pyrrole substituted 2-indolinone protein kinase inhibitors"
MXPA06000933A (en) Aminopyrazole compounds and use as chk1 inhibitors.
WO2002076380A3 (en) Cytotoxic factors for modulating cell death
TW200502385A (en) Modulation of forkhead box o1a expression
UA84954C2 (en) Fused pyrimidones usefuel in the treatment and the prevention of cancer
IL178042A0 (en) Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
AU5173501A (en) Polyamine analogues as cytotoxic agents
HK1033910A1 (en) Use of erythropoietin in the treatment of multiple myeloma
ATE469659T1 (en) STIBOGLUCONATE SODIUM AND IL-2 FOR CANCER TREATMENT
AU2002350623A1 (en) Targeted thrombosis by tissue factor polypeptides
ATE287722T1 (en) AGENT FOR TREATING MALIGNANT DISEASES USING THE PROTEIN YB-1
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
UA88272C2 (en) Use of polypeptides of the cupredoxin family in cancer therapy
HK1079116A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
UA88294C2 (en) Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
WO2005094282A3 (en) Combination therapy comprising cloretazinetm
WO2004053054A3 (en) Nk cell receptor conjugates for treating malignancies
WO2000074667A3 (en) Compositions active in telomere damage comprising a taxane and telomerase inhibitor